Details of the Drug

General Information of Drug (ID: DMDVNVI)

Drug Name

AZD2995

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00692705) Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for Amyloid. U.S. National Institutes of Health.